Jacobs Levy Equity Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-81,579	Closed	-$210K	–	1069
2024 Q2	$210K	Buy	+81,579	New	+$279K	﹤0.01%	918
2023 Q1	–	Sell	-123,821	Closed	-$2.29M	–	1076
2022 Q4	$2.29M	Sell	123,821 -794,454	-87%	-$18.2M	0.02%	528
2022 Q3	$24.8M	Buy	918,275 +854,755	+1,346%	+$17.3M	0.2%	137
2022 Q2	$878K	Sell	63,520 -2,931	-4%	-$45.1K	0.01%	776
2022 Q1	$1.3M	Sell	66,451 -169,073	-72%	-$2.56M	0.01%	713
2021 Q4	$3.84M	Buy	+235,524	New	+$3.93M	0.03%	486
2020 Q1	–	Sell	-65,176	Closed	-$1.06M	–	1111
2019 Q4	$1.06M	Sell	65,176 -182,115	-74%	-$2.82M	0.01%	681
2019 Q3	$3.21M	Buy	247,291 +8,444	+4%	+$103K	0.04%	412
2019 Q2	$3.1M	Buy	+238,847	New	+$3.01M	0.04%	437
2016 Q3	–	Sell	-51,400	Closed	-$699K	–	1151
2016 Q2	$699K	Sell	51,400 -31,490	-38%	-$557K	0.01%	676
2016 Q1	$1.45M	Buy	+82,890	New	+$1.69M	0.03%	487